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An adrerml.spe¢ifie protein reacting with autoantibodi~ in the s:ra of patients with adult onset Addison's dire.am has I:P..¢n purified from human 
e.drenal 81ands, The protein, real.we. 35K, hits the biochemical characteristi~ of steroid 21.hydroxylase and reacts on W~tern blast with rabbit 
antibodies to recombinant 21.hydroxylase, Absorption of the native human 55K adrenal protein with human adrenal autoantibodies prev nted 
the subsequent r~ction of the 55K protein with rabbit :-ntibodies to 21-hydroxylase in W~tcrn blot analysis. In addition, human adrenal 
autoantibodi~ reacted with recombinant 2l-hydroxylas¢ expressed in y~st, These data inditer that the adrenal specific enzyme steroid 21.
hydroxyluse is a major uutoanti~n involved in adult on~t autoimmune Addison's dire.ate, 
Autoimmunity; 21.Hydro"ylase: Addison's ditma~: Adrenal autoantibody 
I. INTRODUCTION 
Adult onset autoimmun, Addison's disease is char- 
acterised by adrenal autoantibodies [I,2] which react 
with a 55K adrenal.specific protein [3], We reasoned 
that this adrenal-specific antisen might be the adrenal- 
specific enzyme steroid 21-hydroxylas¢. Consequently 
we purified the enzyme and studied its interaction with 
adrenal autoantibodies. 
2. MATERIALS  AND METHODS 
2, I. Patients' sofa, tissue samples cmd autea~)lihod.v measuremetlrs 
S=ra from 36 patients with adult on~t Addison's disease (diagnosed 
on the busts of clinical and biochemical dronal insufficiency} were 
studied, In addition, sera from patients with a variety of autoimmune 
di:eat, s were analysed (10 Hashimoto's dimase, l0 Graves' disease. 
$ rheumatoid arthritis, 4 primary billow cirrhosis and 5 lupus erythe- 
motor.s), Also, sera from I0 individual h~althy normal subjects and 
a pool ofsera from 9 normal healthy subjects were included, Autoanti- 
bodi~ r~eting with adrenal, thyroid, lmooth mmcle, ~astric parietal 
cells and pancrex~ were astmsled by immunofluorescentm usin~ unfixed 
ti=su= suctions i  2 separate laboratories. In addition, adrenal and 
thyroid autoantibodi¢.s in orr~ sera were studied hy immunopre¢ipita- 
tins of ml-labelle.d adrenal or thyroid mierosomal preparations a  
described previously [3]. Other autoantibodi=s were measured using 
kits obtained from RSR Ltd., Cardiff, UK. Human adrenal ~lands 
were recovered from redundant tissue surrounding the kidneys re- 
moved from ~davcric donors, human pla~nta was obtained at deliv- 
ery, and human thyroid tissue wa~ obtained at thyroidectomy for 
Grave,¢ di=eas¢. 
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2.2. I#ohttimh soluhilisatlon atM purlfleation of tissue mltrosomal fia¢. 
tlutJs 
Mieroiomal pellets were isolated from tltsue homog~natm as de. 
lcribe.d previously [~i] and storcnl at -70"C, When require, the i~llett 
were solabili~d using 3`$ sodium eholate in 1119 mM phmphate buffer 
pH 7.0 containing 20'$ iilyr~rol. 0.1 mM r.DTA and 0,1 mM D'i 'r 
(basal buffer) as der, cril:~.M previously [4,$l, Solubilir, cd micromm~ (6 
ml), were run on a i x 10 can column of Octyl.S~pharo~ {Pharmaeia) 
and el,Jted with ba~l buffer (25 ml}, Fractions (3 ml) were monitorad 
at OD~t~,,~ (to detect otal protein) and at OD, tm,. (to ¢let~t yro- 
chrome p450 proteins [5]). Further elution was carried out usina in. 
creasing concentrations of Emulgen 913 (Kayo-Atlas) in the bml  
buffer, Aliquots from groups of fractions wore then i:moled, con¢cn- 
trated (Centricon I0 microconcentrator~) andanalyr, ed for the pres. 
once of adrenal antig=n by a variety of procedures. 
2,3, Polyacr.rlamM¢ gd e/¢ctroplmrrsis (SDS.PAGE) and Western 
hints 
Sampl~ (crude solubilir, ed microsomes or fractions from the O~tyl- 
Sepharor¢ column) wera analysed on i~olyacrylamide g ls (9%) under 
reducing conditions [6l, After ¢l,¢trophor~i$, ~ls were either stained 
with Coomar~ie blue, f~ed and dried or blotted otato nitrocellulo~.,, 
membranes, In some experiments, the protein band ol'inter~t wascut 
out from the stained sol and the protein electroeluted, Western blot 
analysis was carried oat using the 'renaturinll ° modification of Birk 
and Ko=pr~ll [71, After rcnaturation, tho mcmbran~ wc~ reacted with 
Addison or control r~ra (h40~ dilution) follow~M by anti.human im- 
munoglobulin-hor~radish l'monid=~ conju@te (Amemlmm). After 
reaction with a chcmiluminescen~ generating substrate (ECL s:wtem 
from Amersham) the nitrocellulose membrane strilzi were expo~l to 
photographic film for tmtwecn 10-450 s and then developed. In some 
experiments, rabbit antibody to r~.ombinant s eroid 21-hydroxyla= 
[8] and rabbit antibody to mierosomal epozide hydr©la~ [91 wet, us~l 
in combination with anti.rabbit lgG hor~radish l~roxida~ =nju- 
~at¢, 
2.4. Anat,,sis hy dot blot 
In the case of dot blot analysis, adrenal amigcn was applied to 
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Fig. l, (A) Elution of adrenal microsolmtl proteins run on Octyl-Sepharor==. (B) Western blot analysis of adrenal nlicrosomal proteins eluted from 
O¢tyl.Sepharo~. 
nitrocellulose mcmbmncl and allowed to dry. The procedure then 
followed tile protocol for Western blot analysis as described above. 
2.5. Ex'presdon of 21.hydro.D'las¢ i, gaccharomyces cerevisia¢ 
The 2l.hydroxyla~ gen¢ in pCD/IpC2 t/3c [tO] (ATCC) was modi- 
fied by replacing the first 13 amino acids with the first 14 amino acids 
ofSTE2 gene and placed under the control of the GALl promoter in 
pYES 2.0 (lnvitrollen), The 21.hydroxylase ~ne was gut:cloned from 
pCDIIpC2I/3¢ at a BmnHI fragment into the v~:tor pTZI8 (Pharma- 
cia), Digestion with $phl followed by partial digestion with Nor[ 
yielded a large fray'neat comprising the entire coding region of 21- 
hydroxylar~ apart from 41 base pairs at the Y end. Thi,t was then 
ligated into pYF..5 cut with Ban=HI and $ph[ using a BamHl-h'arl 
linker comprising 11 base pairs of non.codi,li and 42 base pair; of 
STE'2 coding sequence [I !], TransFormants of $acc/utrom,t'cex revix. 
iae (CI3 ABYS riB) were grown in selective media and used to inocu. 
late expression cultures in YEP.gluco~: (2%)or YEP.Qalacto~ (2%), 
After 4g h at 30'C, the cells were harvnated, broken by reflexing with 
glass I~.ads in l~  sodium deoxycholat¢ and analysed on SDS-PAGE 
followed by W~tern blotting. 
2.6, Absorption of adrenal anti&eft with atlrenu/ atuibodie,~ 
lgG was purified from normal pool scra and individual patient sera 
using chromatography on protein A-glass bead columns (Bio- 
processing Consett, UK). Aliquots of purified adrenal protein were 
incubated with the IgOs (2-~i mg.ml "~) for I h at 37"C, A protein 
A-gin.  bc~td SUsl~nsion in PB5 was then added to bind frcc IgG and 
lgG complexed to adrenal antigen(s). After i h at room temperature, 
the mixture was centrifuged (12,0Q0 xg, 10 nlin, 4'C) and the super- 
natants analysed by SD$.PAGE and Western blotting using Addison 
scra and rabbit antibodies to recombinant 21-hydroxylase, 
3. RESULTS 
3.1.  Sohtbilisrztio. and purification of adrenal micro. 
A typ ica l  e lu t ion  pro f i le  o f  adrena l  mic rosomal  p ro -  
teit~s run on Octyl-Sepharose ix shown in Fig. IA. Frac- 
tions ¢luting from tho column were pooled, concen- 
trated and designated l-VIII as shown in Fig, I A. Anal- 
ysis on SDS-PAGE showed that most of the protein was 
present in fractions I, II and III. Fractions IV to VIII 
contained much less protein and this was resolved prin- 
cipally into 3 Coomassie-stained bands with M, = 51 K, 
55K and 60K (data not sht~wn), The highest concentra- 
tion of the 55K band was present in fi'action VI and 
Western blot analysis using adrenal autoantibody posi- 
tive sara indicated that the autoantibodies recognised a 
55K protein most of which was present in fraction VI 
(Fig, I B), Parallel studies were carried out in which 
solubilised placental microsomal proteins were sepa- 
rated on an Octyl-Sepharos¢ column and analysed by 
Western blotting. None of the column fractions con- 
tained material which reacted specifically with adrenal 
autoantibodies (data not shown). Western blot analysis 
of fraction VI showed that rabbit, antibody to 21-hy- 
droxyla~, reacted specifically wit!: the 55K protein (Fig. 
2, lanes 2 and 3) wlx=r=as an antibody to epo~ide hydro- 
lose reacted with a protoin of mol.wt. 49K (Fig. 2, lane 
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Fill, 2, Western blot analDi,= of fraction '/ I  of Octyl.S=pharorm col- 
umn. Lane I, reaction with normal pool s¢rum, Lane 2, reaction with 
adrenal autnant ibody positive ~¢rum. Lane 3, reaction with rabbit 21- 
hydroxylase antibody, Lane 4, reaction with normal rabbit serum. 
Lane 5, ~¢actio. wlth rabbit epoxide hydrola~ antibody. 
5). In some experiments, the 55K band from SDS- 
PAGE analysis of fraction VI was cut out of the gel, 
electro,luted0 run on PAGE to confirm homogeneity 
(data not shown) and analysed by Western blot. The 
eluted band reacted strongly with adrenal autoantibody 
positive serum and with rabbit antibody to 21-hydrox- 
ylase but not with epoxide hydrolase antibody nor with 
normal pool haman =¢rum, nor with normal rabbit 
serum (Fig, 3). 
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Fill, 3, Wcst¢rn blot anai]tr, i= of SSK adrenal protein ¢lcr.troe.Jutcd from 
an SDS.PAGE run. Lane i, reaction with nomml pool fmrurn, i.~nc 
2, maction with adrenal nut.antibody po=itivc ~rum. Lane 3, r~ction 
with rabbit 21.hydroxylu= antibody. L.m~¢ 4, rcm:tion with rabbit 
epoxid¢ hydrola~¢ antibody, Lane 5, reaction with normal rabbit 
~i4ffunl. 
3.2. Expression of  2l-hydroxy/as¢ in Saccharornyces 
cerevisia= 
Adrenal autoantibodies and rabbit antibodies to 21- 
hydroxylase reacted strongly and specifically with a 
55K protein expressed in transformed yeast (Fi$. 4. 
lanes 5 and 6). Normal pool human .~rm'n and normal 
rabbit serum did not react with this 55K protein band. 
In addition, adrenal autoantibodics and rabbit antibod- 
ies to recombinant 21.hydroxylase did not react spccifi- 
rally with any proteins expressed in non-transf0rmcd 
yeast or yeast expressing human thyroid l:mroxidase 
(Fig. 4. lanes 9,2 and 8,3 respectively). Furthermore, 
expression of the 55K protein band recognised b:~ au- 
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Fi 8. 4. AnalyEis of" yeast extracts by SDS-PAGE and Western blotting. Lanes I and 10. native 21.hydro~ylat¢, Lan~ 2 and 9, extract from 
no.-transformcd yeast, Lan~ 3 and 8, extract from yeast expr~sin 8 human thyroid pcroxidas¢, Lan~ 4 and 7. extract from y~ast transforme.d 
with 21.hydroxylus¢ Ben= grown in medium to.ruining glucose, l.~nes 5 and 6, extract from yeast trdn,~formed with 21.h.'vdroxylas¢ Sene grown 
in medium containing Balactose, (A) Reaction with rabbit antibody I.o 21-hydroxylase. (B) Re.action with adrenal autoantibody positive ~rtAm, 
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toantibodies and rabbit antibodies was clearly increased 
in transformed yeast grown in galactose xpression me. 
dium compared to glucose xpression medium (Fig. 4. 
lanes 6.7 and 4,$ respectively). 
3.3. Absorption studies 
Western blot analysis indicated that rabbit antibody 
to recombinant 21.hydroxylaa¢ did not react with native 
adrenal 55K protein which had been pro-absorbed with 
IgG from human adrenal autoantibody positive Ad- 
dison sera (data not shown), Pro.absorption with nor- 
mal pool serum IBG had no effect on reactivity with 
21-hydroxylase antibody. 
3.4. Analy.~is of serum ,,'utopias by dot blot assay 
Out of 35 Addison sara studied. 26 (72%) showed the 
presence of adrenal autoantibodies by immunofluores- 
canoe, immunoprecipitation, or Western blotting (Table 
l), All 26 of these sere were also positive by dot blot 
assay using purified native human adrenal antigen 
(Table I). Ten Addison sere were negative for the pres- 
ence of adrenal autoantibodies by immunofluorescen~, 
immunoprecipitation or Western blotting and all of 
these I0 were negative by dot blot assay. Only one of 
the 44 control sara studied wa~ positive for adrenal 
autoantibodies in the dot blot assay, This serum was 
from a patient with Graves' diseas~ and type II diabetes 
mellitus, and the presence of autoantibodies reactive 
with the 5SK adrenal protein was confirmed by Western 
blotting. 
Table I 
Autoantibody a .ays  in patiems with adult onset Addison',= dirca~ 
Adrenal Autoaatibody ~,ssays Thyroid Autoantibodies 
Addison patient Dot aim Western Blot Immune, lmmunopmeip TgAb TPOAb TRAb Olher Autoanti- 
No. tluore,~cencc U/ml U/ml bodies 
1 ÷ ÷÷÷÷ nt nt 0.6 30 ne 8 
2 + ÷+÷+ nt nt 16 30 neE. 
3 + +++ nt nt 14.5 30 45.~ 
4 + ÷ ÷ ÷ nt nt 6 30 nell 
$ ÷ +÷ nt nt i~¢g 2.7 neE. 
6 ÷ + * + 30 30 91,9 a,b,¢ 
7 ÷ ÷+ nt nt 1.2 21 ned 
8 ÷ + m nt ned 2.0 ne 8 
9 + + m m nee 26 neE. 
10 + + m nt 12.5 17 neE. 
i I ÷ ÷+÷ nt n| .1..~ 1.9 neE. 
12 * ÷+ ÷ ÷nt 20 8.9 nell. a,¢,d 
13 ÷ ÷+ nt nl neE, nell no B 
14 ÷ + m + 0.5 21 neE. 
15 + nt .~. + neE. neE. neE. c,e 
16 + nt + ÷ ned neE. neE. 
17 + m +÷ ÷ 2. .  ~ 30 neE. b,c,8 
18 + + + + neE. n o8 nell ¢ 
19 + + + + 1,9 21 nor ¢ 
20 + + + + ncg 1.7 neE. ¢ 
21 + + ÷ + neE. 2 5 nag c 
22 + + + ÷ 16 34 18,3 
23 + ÷ + ÷ 30 30 neE. d,e,f 
24 + + ÷ ÷ 11.4 12 6,8 
25 ÷ + + at 30 30 47,(~ ¢ 
26 ÷ + + nt 8.2 30 noE. ¢ 
2"1 nab nt nab neE. n¢E. neE. ~leB 
28 nab at neE. ne E neE. neE. no B 
29 nee nt nab neE. ned neE. nee 
30 nag n~ neE. neE. 0.4 8.6 nag d 
31 ned nt ned neE. nee ned ace c,d 
32 n¢8 nt neE. ncg n~8 5,0 nQ8 
33 nob nt n~8 nag nab nab nag 
34 n¢8 ned nt nt nag neE. ned 
35 nab ned nt nt ned ned neE. 
36 ned nee nag nee ned ned nell 
a = antitubulin antibodies; b = anti-islet ~11 antibodieg ¢ = anti-parietal ¢~11 antibodies; d = ami-nu¢loar antibodies; ¢ = anti.mho~hondrial 
antibodies; f -- anti.dasmin antibodies; 8 = anti-steroid producing ~11 antibodies; nt = not to,ted. 
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4, DISCUSSION 
Chromatography of solubilised adrenal microsomes 
on Octyl-Sepharose indicatcd that a protein band of 
55K was elated principally in fraction VI with smaller 
amounts of 55K protein in fractions IV, V and VII (Fig. 
IA). Previous tudies with Octyl-Sepharos¢ chromatog- 
raphy have shown that 21.hydro~ylase i  lated in sim- 
ilar column fractions [5]. Western blotting showed that 
adrenal autoantibodies recognised the adrenal 55K pro- 
tein in the column fractions and this reaction was by far 
the strongest in fraction VI (Fig. I B). Ti~u¢ specificity 
of the autoantibody reaction was confirmed using pla- 
ccn:al material purified in the same way. Western blot 
analysis indicated that adrenal autoantibodics and anti- 
bodies to recombinant human 21-hydroxylase reacted 
with the adrenal 55K protein present in column fraction 
VI (Fig. 2). In addition, both types of antibody reacted 
with the 55K adrenal protein after ¢lectroelution from 
SDS-PAGE (Fig. 3). Furthermore. absorption studies 
confirmed that the 55K adrenal protein r¢cognised by 
adrenal autoantibodies and rabbit 21-hydroxylase anti- 
bodies was indeed the same protein, Finally, when 21- 
hydroxylas¢ was expressed inyeast, it was recognistd by 
adrenal autoantibody positive Addison s~ra and rabbit 
antibody to recombinant human 2l-hydroxylase. Du- 
an Wu et al, [12] used a similar system to ~press enzy- 
t~tically active human 21-hydroxylas¢ in yeast. Conse- 
quently, 4 different approaches involving (i) purifica- 
tion of native human adrenal proteins; (ii) Western blot- 
ting with Addison sere and rabbit antibody to recombi- 
nant 21.hydroxylase; (iii) antibody absorption studi~ 
and (iv) expression of human 21-hydroxylase in yeasL 
indicate that 21.hydroxylase is a major autoantigen i
adult type Addison's disease. In order to develop an 
assay for 21-hydroxylas¢ autoantibodies, weevaluated 
the use of the Octyl-Sepharose column fraction V[ (Fig, 
I) in a dot-blot system. Out of 36 Addison sera analysed 
i'or adrenal amoantibodies bydot-blot assay, 26 (72%) 
were positive. Adalysis of the sera by immunofluores- 
c~nc~ and/or immunoprecipitation and/or Western blot, 
confirmed the presence of adrenal autoantibodies in all 
26 dot-blot positive sere (Table I). The I0 Addison sera 
negative by dot-blot assay were also negative in the 
three other systems us,~l to detect adrenal autoantibod- 
ies (Table I). In dot-blot assays cf:ontrol sere. only one 
serum (from a patient with Graves' disease) was found 
to be positive, This positive Graves' .~erum was con- 
firmed to have antibodies reactive with the 55K band 
on Western blot. Our observations with the dot blot 
assay are in good agreement with previous studies of 
large numbers of sera using immunofluoresccn~ [13- 
15] with most studies reporting adrenal utoantibodies 
in a few patients with non-adrenal utoimmune dis:a~ 
including Graves' disease [13-15]. Our data indicate 
therefore that the dot-blot system based on partially 
purified 21-hydroxylase provid¢, a s¢nsitive, specific 
m~thod for measuring 21-hydroxylas¢ autoantibodi~. 
In view of our results and the recent findinbs by Krohn 
et al, [15], it would apl~ar that two distinct crmymes, i.e. 
17-alpha-hydroxylase nd 2I-hydroxyla~ are the au- 
toantigens involved in two clearly.distinct forms of Ad- 
dison's disease [2,17]. In early onset Additon's di~a.~ 
which is most commonly associated with hypoparathy- 
roidism and mucocutaneous candidosis (type I pol>'cn- 
docrine autoimmune syndrome) autoantibodies ~,em to 
be directed against 17~t.hydroxylase [16] whereas in 
adult onset Addison's diP.as¢, autoantibodi~ are di- 
rect~ against 21-hydroxylas¢, 
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